netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Ondansetron found 8 matches
Open monograph to display formulary status BNF Category
  Ondansetron Central nervous system - 5HT3 antagonists - 04.06
  Ondansetron INJECTION Central nervous system - Drugs used in nausea and vertigo - 04.06
  Ondansetron INJECTION
(palliative care) 		Palliative Care Formulary - Nausea and Vomiting - 21.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Alert (Jul 2013): Ondansetron for intravenous use: dose-dependent QT interval prolongation (04.06)
link in drug section MHRA Drug Safety Alert (Jul 2013): Ondansetron for intravenous use: dose-dependent QT interval prolongation (21.05)
link in drug section MHRA Drug Safety Update (Jan 2020): Ondansetron: small increased risk of oral clefts following use in the first 12 weeks of pregnancy (21.05)
link in drug section MHRA Drug Safety Update (Jan 2020): Ondansetron: small increased risk of oral clefts following use in the first 12 weeks of pregnancy (04.06)
link in drug section MHRA Drug Safety Update (Jan 2020): Ondansetron: small increased risk of oral clefts following use in the first 12 weeks of pregnancy (04.06)


 
netFormulary